Overview

Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression

Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The primary study comparing effectiveness for suicidal ideation and/or behavior of two antidepressant medications in depressed patients who have attempted suicide or are currently experiencing suicidal thoughts has been completed. A secondary study component using functional magnetic resonance imaging (fMRI) to investigate different medication effects on reward processing in the same sample is ongoing.
Phase:
Phase 4
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Bupropion
Paroxetine